Search research articles
Contact Us
Filters
Showing results (131-140 of 144) with videos related to
Page
of 15
Sort By:
Nature Communications
|
July 17, 2020
ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment
Chi-Lam Au-Yeung, Tsz-Lun Yeung, Abhinav Achreja, et al.
Cancer Cell
|
December 8, 2009
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2
Samuel C Mok, Tomas Bonome, Vinod Vathipadiekal, et al.
Plos One
|
July 15, 2011
Identification of novel therapeutic targets in microdissected clear cell ovarian cancers
Michael P Stany, Vinod Vathipadiekal, Laurent Ozbun, et al.
Cancer Science
|
July 15, 2009
Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma
Ozge Alper, William G Stetler-Stevenson, Lyndsay N Harris, et al.
Gynecologic Oncology
|
April 25, 2025
Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics
Kari L Ring, Anne M Mills, Brooke E Howitt, et al.
International Journal of Cancer
|
December 10, 2008
Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women
Tony K H Chung, Tak-Hong Cheung, Ngar-Yee Huen, et al.
JCI Insight
|
August 18, 2017
Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens
Archana S Nagaraja, Robert L Dood, Guillermo Armaiz-Pena, et al.
JCI Insight
|
June 12, 2018
Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens
Archana S Nagaraja, Robert L Dood, Guillermo Armaiz-Pena, et al.
JCI Insight
|
April 1, 2021
Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens
Archana S Nagaraja, Robert L Dood, Guillermo Armaiz-Pena, et al.
Journal of the National Cancer Institute
|
March 17, 2021
Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival
Lari Wenzel, Kathryn Osann, Chelsea McKinney, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 144) with videos related to
Sort By:
Page
of 15
Nature Communications
|
July 17, 2020
ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment
Chi-Lam Au-Yeung, Tsz-Lun Yeung, Abhinav Achreja, et al.
Cancer Cell
|
December 8, 2009
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2
Samuel C Mok, Tomas Bonome, Vinod Vathipadiekal, et al.
Plos One
|
July 15, 2011
Identification of novel therapeutic targets in microdissected clear cell ovarian cancers
Michael P Stany, Vinod Vathipadiekal, Laurent Ozbun, et al.
Cancer Science
|
July 15, 2009
Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma
Ozge Alper, William G Stetler-Stevenson, Lyndsay N Harris, et al.
Gynecologic Oncology
|
April 25, 2025
Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics
Kari L Ring, Anne M Mills, Brooke E Howitt, et al.
International Journal of Cancer
|
December 10, 2008
Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women
Tony K H Chung, Tak-Hong Cheung, Ngar-Yee Huen, et al.
JCI Insight
|
August 18, 2017
Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens
Archana S Nagaraja, Robert L Dood, Guillermo Armaiz-Pena, et al.
JCI Insight
|
June 12, 2018
Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens
Archana S Nagaraja, Robert L Dood, Guillermo Armaiz-Pena, et al.
JCI Insight
|
April 1, 2021
Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens
Archana S Nagaraja, Robert L Dood, Guillermo Armaiz-Pena, et al.
Journal of the National Cancer Institute
|
March 17, 2021
Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival
Lari Wenzel, Kathryn Osann, Chelsea McKinney, et al.
Page
of 15